The intertwined expansion of telehealth and buprenorphine access from a prescriber hub.
Prev Med
; 152(Pt 2): 106603, 2021 11.
Article
em En
| MEDLINE
| ID: mdl-33974959
ABSTRACT
In this manuscript, we describe how efforts to increase access to buprenorphine for Opioid Use Disorder (OUD) through a telemedicine hub before and since the COVID-19 pandemic have played out in the Veterans Healthcare Administration (VHA) in New England. We look at how the COVID-19 pandemic and subsequent spike in opioid overdoses tilted the risk benefit calculation for tele-prescribing a controlled substance such as buprenorphine toward expanding access to tele-buprenorphine. We conclude that there is a need for tele-buprenorphine hubs that can fill gaps in geographically dispersed healthcare systems.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Buprenorfina
/
Telemedicina
/
COVID-19
/
Transtornos Relacionados ao Uso de Opioides
Limite:
Humans
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article